Fortis

Deal values diagnostic arm at Rs 5,700 crore

A well-known private healthcare group, Fortis on Friday inaugurated a state-of-the-art facility for the specialised treatment of blood cancers and disorders, which it said "represented a critical step" in addressing the urgent need for comprehensive holistic care. The Fortis Institute of Blood Disorders also integrates paediatric and geriatric care, advanced transplant procedures, and hematopathology expertise, all under one roof, Fortis Healthcare said in a release. The Institute also launched CAR-T cell therapy to its extensive network of Bone Marrow Transplant centres in Mohali, Delhi, Gurgaon, Noida, Mumbai and Bangalore, the statement said. This initiative is supported by a commercial collaboration with ImmunoACT, an IIT-Bombay spin-off and pioneer in India's first fully indigenous and commercially approved gene-modified cell therapy. The NexCAR19, India's first market-authorised CAR-T cell therapy, offers a new ray of hope for treating B-cell lymphomas and B-acute lymphoblast

Fortis Healthcare on Monday said it has tied up with emergency response network RED.Health to offer end-to-end emergency services. The collaboration is driven by a shared vision to provide end-to-end emergency services within the minimum response time and reduce trauma and fatalities during medical emergencies, the healthcare major said in a statement. The scope of the collaboration spans across seven branches of Fortis Hospitals in Delhi/NCR, it added. As part of the collaboration, RED.Health will deploy 10 dedicated GPS-enabled advanced life support (ALS) ambulances and also support patient logistics with an independent fleet of over 30 vehicles in NCR, ensuring that ambulances reach patients within around 10 to 30 minutes, it said. Additionally, a concierge will be available at each hospital for better coordination between the patient and the ambulance, it added. "With this partnership, patients in need will be able to reach a Fortis emergency within minutes, from wherever they

The transaction will be an all-cash deal and is estimated to be consummated by the end of July 2023, subject to certain conditions as stipulated in the definitive agreements

The 500 robot-aided surgeries include complex robotic procedures encompassing the entire gamut of Uro-Oncology, Uro-Gynaecology, Reconstructive Urology and Kidney Transplant

Malaysia's IHH Healthcare on Friday said it is ready to proceed with its stalled open offer for 26.1 per cent stake in Fortis once capital markets regulator SEBI gives it a go-ahead. The company, which currently is the largest shareholder in Fortis with a 31.17 per cent stake, said it remains fully committed to Fortis and India. "We certainly understand the frustration Fortis investors have felt over the past four years around the uncertainty of the IHH open offer. With the recent Supreme Court judgement ruling making clear that we have conducted our investment into Fortis in a fair and transparent manner, we are discussing with Securities and Exchange Board of India (SEBI) to move ahead with the offer," IHH Healthcare Managing Director and CEO Kelvin Loh said in a statement. Should they concur and approve, IHH is ready to proceed with the open offer as soon as possible, he added. Loh said Fortis is IHH's key growth platform in India. "We are hopeful for a positive outcome so that

The Supreme Court on Friday agreed to hear during the day itself a plea seeking grant of interim bail to former promoter of Fortis Healthcare Ltd Malvinder Mohan Singh in view of the critical condition of his wife. A bench comprising Chief Justice Uday Umesh Lalit and Justice Bela M Trivedi took note of the submissions of senior advocate Kailash Vasudev, appearing for Singh, that the plea be heard urgently as the condition of his wife is critical due to decrease in her platelet count The top court issued notice to the standing counsel of the Delhi government and posted the plea for hearing at 1 pm. Singh is presently lodged in Tihar jail in a case related to alleged misappropriation of funds at Religare Finvest Limited (RFL). In September this year, the Supreme Court awarded a six-month jail term to Singh in a contempt case related to the sale of shares of Fortis to Malaysia-based IHH Healthcare.

The rupee closed at a record low of 80.86 to the dollar, down from 79.9750 in the previous session

Initiative provides counselling, webinars to create a culture of openness and acceptance about mental health and real-time text chat support by a team of psychologists

Fortis Healthcare on Monday said a US-based entity has filed a suit against it and various others, including IHH Healthcare Berhad

A vacation bench of Justice Anu Malhotra issued notice to Fortis Hospital at Vasant Kunj and also asked it to again conduct RT-PCR test on the 18-year-old student

Company to also launch a digital solution for all healthcare needs and plans to rope in partners

Fortis already operates a 170-bed multispecialty hospital in the city

Total income during the quarter fell by 47 per cent to Rs 610 crore

The third quarter of 2019-20 continues to witness earnings growth with margin expansion in the hospitals business

ED took the accused in its custody inside the Tihar central jail here

The Singh brothers had moved a bail plea which will be heard later along with that of Arora tomorrow

FIR against Singh brothers, Godhwani, others for misappropriation of funds, forgery, criminal conspiracy

Net profit for the third quarter of this fiscal year was primarily impacted by exceptional losses

Fortis further clarified the order does not impact the preferential allotment made to Northern TK Ventures by Fortis on Nov 13, in accordance with the applicable law